Article
Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay.
Microbiology spectrum - 27 Apr 2022
Galati Luisa, Combes Jean-Damien, Le Calvez-Kelm Florence, McKay-Chopin Sandrine, Forey Nathalie, Ratel Mathis, McKay James, Waterboer Tim, Schroeder Lea, Clifford Gary, Tommasino Massimo, Gheit Tarik
Abstract excerpt
Human papillomavirus (HPV) circulating tumor DNA (HPV ctDNA) was proposed as a biomarker for the detection and disease monitoring of HPV-related cancers. One hundred eighty plasma samples obtained from women diagnosed with HPV16-positive cervical cancer (CC) (n = 100), HPV16-positive premalignant lesions (cervical intraepithelial neoplasia grade 3 [CIN3]) (n = 20), and HPV DNA-negative controls (n = 60) were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
